newsfilter
← Latest News
PR Newswire·

Avidity Biosciences Reports Second Quarter 2025 Financial Results and Recent Highlights

Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody...